An Act relative to PANDAS/PANS screening in medical/clinical settings
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Overview
This bill aims to establish guidelines for screening patients for Post-Acute Neuropsychiatric Disorder Associated with Influenza (PANDAS) and Pediatric Acute Neuropsychiatric Syndrome (PANS) in medical and clinical settings. Currently, there isn’t a standardized approach to diagnosing these conditions, leading to inconsistent care and potential delays in treatment. The bill seeks to improve diagnostic practices and ensure patients receive appropriate support and management.
Key provisions
- Requires medical professionals to be educated on PANDAS and PANS.
- Encourages the development of standardized screening protocols.
- Promotes the inclusion of PANDAS and PANS in clinical evaluations.
- Supports research into the diagnosis and treatment of these disorders.
Who is affected
- Patients with PANDAS or PANS
- Healthcare providers (physicians, therapists, etc.)
- Families of affected individuals
Notable changes
- The bill does not mandate specific screening tests but advocates for their consideration.
- It focuses on improving awareness and education within the healthcare system.
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
3 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours